Management of intractable nausea and vomiting in patients at the end of life - " I was feeling nauseous all of the time ... nothing was working"

被引:58
|
作者
Wood, Gordon J. [1 ]
Shega, Joseph W. [1 ]
Lynch, Beth [1 ]
Von Roenn, Jamie H. [1 ]
机构
[1] Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA
来源
关键词
D O I
10.1001/jama.298.10.1196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nausea and vomiting, symptoms that occur commonly near the end of life, represent a substantial source of physical and psychological distress for patients and families. In the context of the case of MrQ, a 50-year-old man with metastatic esophageal cancer admitted to the hospital with intractable nausea and vomiting, we review the evaluation and treatment of this symptom complex. A thorough history and physical examination are essential first steps in the management of these patients because they define the severity of the symptoms and clues to their underlying etiology. Once the most likely cause is determined, the clinician discerns the mechanism, specific transmitters, and receptors by which this etiology is triggering nausea and vomiting. Subsequent pharmacological management focuses on prescribing the appropriate antagonist to the implicated receptors. If symptoms are refractory despite adequate dosage and around-the-clock prophylactic administration, an empirical trial combining several therapies to block multiple emetic pathways should be attempted. Less traditional agents are also discussed, although evidence for their use is limited. Often, oral administration of medication is not feasible and alternate routes such as rectal suppositories, subcutaneous infusions, and orally dissolvable tablets should be considered. Using this step-wise approach, nausea and vomiting can be successfully managed in most patients at the end of life.
引用
收藏
页码:1196 / 1207
页数:12
相关论文
共 8 条
  • [1] Management of intractable nausea and vomiting in patients at the end of life - "I was feeling nauseous all of the time ... nothing was working"
    Markowitz, Amy J.
    Rabow, Michael W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15): : 1826 - 1826
  • [2] Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life: A systematic review
    Pan, CX
    Morrison, RS
    Ness, J
    Fugh-Berman, A
    Leipzig, RM
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (05) : 374 - 387
  • [3] Long-Term Daily Administration of Aprepitant for the Management of Intractable Nausea and Vomiting in Children With Life-Limiting Conditions: A Case Series
    Patel, Bhumik
    Downie, Jonathan
    Bayliss, Julie
    Stephenson, Andrea
    Bluebond-Langner, Myra
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 62 (03) : E225 - E231
  • [4] Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting
    Ross, DD
    Alexander, CS
    [J]. AMERICAN FAMILY PHYSICIAN, 2001, 64 (05) : 807 - 814
  • [5] Management of chemotherapy-induced nausea and vomiting in adult patients after haematopoietic stem cell transplantation: adherence to guidelines and costs analysis from the Quality of Life Working Party of the Rome Tranplant Network
    Tendas, A.
    Sollazzo, F.
    Niscola, P.
    Cupelli, L.
    Carlo, C.
    Mauroni, M. R.
    Ciaralli, I.
    D'apolito, A.
    Pilozzi, V.
    Cacciaraichi, S.
    Viggiani, C.
    Pignatelli, A.
    Annibballi, O.
    Mengarelli, A.
    Dentamaro, T.
    De Fabritiis, P.
    Arcese, W.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S467 - S467
  • [6] Survey of the University of Florida hematology/oncology fellows on perceived skills of independent management of oncologic pain, chemotherapy-related nausea and vomiting, and end-of-life discussions
    Ricks, Jennifer Lynn
    Chang, Myron
    An, Qi
    Dang, Nam H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [7] Chemotherapy-induced nausea and vomiting in adult patients after hematopoietic stem cell transplantation: a survey from the Quality of Life Working Party of the Rome Transplant Network (RTN)
    Tendas, A.
    Annibali, O.
    Sollazzo, F.
    D'Apolito, A.
    Cacciaraichi, S.
    Viggiani, C.
    Conte, E.
    Molinari, V.
    Di Veroli, A.
    Chierichini, A.
    Mauroni, M. R.
    Papa, C.
    Saltarelli, D.
    Carli, I.
    Marchesi, F.
    Dentamaro, T.
    de Fabritiis, P.
    Arcese, W.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S207 - S207
  • [8] Cardiac resynchronization therapy defibrillator at the end of battery life; is time to discuss the need to re-implant a device with defibrillator back-up in all patients?
    Taravelli, E.
    Rordorf, R.
    Vicentini, A.
    Petracci, B.
    Savastano, S.
    Sanzo, A.
    Raineri, C.
    Dusi, V.
    De Regibus, V.
    Scelsi, L.
    Ghio, S.
    Visconti, L. Oltrona
    De Servi, S.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 445 - 446